• FDA Approves Juvéderm Vollure XC drugs.com
    March 21, 2017
    Allergan plc, (NYSE: AGN), a leading global pharmaceutical company announced that the company has received approval from the U.S. Food and Drug Administration (FDA) to market Juvéderm Vollure™ XC.
PharmaSources Customer Service